Myeloma news from the 2014 annual meeting of the American Society of Clinical Oncology has included updates on proteasome inhibitors, overcoming drug resistance, monoclonal antibodies and more. In this brief video, Dr. James Berenson, a leading myeloma researcher and physician, gives an overview with a focus on what’s important for patients today.

Read the transcript |

James Berenson, M.D. is the Medical and Scientific Director of the Institute for Myeloma and Bone Cancer Research (IMBCR) in West Hollywood, California.

View more programs featuring Dr. Berenson |

Get email alerts |

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Like on Google Plus |

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…